Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-04-02 Purchase | 2024-04-03 6:50 pm | Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner | 485,250 | $0.76 | $368,790 | 11,227,923 (Direct) | View |
2024-04-01 Sale | 2024-04-02 6:38 pm | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 2,000 | $72.96 | $145,920 | 96,304 (Direct) | View |
2024-02-28 Sale | 2024-02-29 6:35 pm | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 10,230 | $72.82 | $744,984 | 92,706 (Direct) | View |
2024-02-12 Purchase | 2024-02-13 5:48 pm | Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner | 910,000 | $22 | $20,020,000 | 4,126,119 (Direct) | View |
2024-01-29 Purchase | 2024-01-31 5:00 pm | Arcus Biosciences Inc. | RCUS | GILEAD SCIENCES INC. 10% Owner | 15,238,095 | $21 | $319,999,995 | 30,061,124 (Direct) | View |
2024-01-16 Sale | 2024-01-17 6:01 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 5,000 | $85.78 | $428,900 | 101,534 (Direct) | View |
2024-01-09 Sale | 2024-01-10 3:58 pm | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 8,242 | $85.23 | $702,466 | 82,729 (Direct) | View |
2023-10-17 Sale | 2023-10-18 4:31 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 5,000 | $80 | $400,017 | 104,003 (Direct) | View |
2023-09-12 Sale | 2023-09-13 6:50 pm | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 1,501 | $76.99 | $115,562 | 70,130 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-25 Exercise | 2024-04-26 4:30 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 515 | $0 | 53,682 (Direct) | View |
2024-04-25 Tax Withholding | 2024-04-26 4:30 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 158 | $65.27 | 53,682 (Direct) | View |
Ownership | 2024-04-19 4:31 pm | N/A N/A | LEAP THERAPEUTICS INC. | LPTX | GILEAD SCIENCES INC. 10% Owner | 0 | $0 | 5,319,148 (Direct) | View |
Ownership | 2024-04-03 6:48 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner | 0 | $0 | 6,860,223 (Direct) | View |
2024-03-28 Option Award | 2024-03-29 5:19 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Lofton Kevin E Director | 34 | $0 | 3,258 (Direct) | View |
2024-03-10 Tax Withholding | 2024-03-12 4:19 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 846 | $75.12 | 138,088 (Direct) | View |
2024-03-10 Exercise | 2024-03-12 4:19 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 2,555 | $0 | 138,088 (Direct) | View |
2024-03-10 Option Award | 2024-03-12 4:19 pm | N/A 2034-03-10 | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 65,795 | $0 | 138,088 (Direct) | View |
2024-03-10 Tax Withholding | 2024-03-12 3:57 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 790 | $75.12 | 94,565 (Direct) | View |
2024-03-10 Exercise | 2024-03-12 3:57 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 2,682 | $0 | 94,565 (Direct) | View |
2024-03-10 Option Award | 2024-03-12 3:57 pm | N/A 2034-03-10 | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 18,485 | $0 | 94,565 (Direct) | View |
2024-03-10 Tax Withholding | 2024-03-11 9:14 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 4,803 | $75.12 | 304,272 (Direct) | View |
2024-03-10 Exercise | 2024-03-11 9:14 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 10,401 | $0 | 304,272 (Direct) | View |
2024-03-10 Option Award | 2024-03-11 9:14 pm | N/A 2034-03-10 | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 107,300 | $0 | 304,272 (Direct) | View |
2024-03-10 Tax Withholding | 2024-03-11 9:11 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 13,782 | $75.12 | 1,080,883 (Direct) | View |
2024-03-10 Exercise | 2024-03-11 9:11 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 29,940 | $0 | 1,080,883 (Direct) | View |
2024-03-10 Option Award | 2024-03-11 9:11 pm | N/A 2034-03-10 | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 334,040 | $0 | 1,080,883 (Direct) | View |
2024-03-10 Tax Withholding | 2024-03-11 9:03 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 4,559 | $75.12 | 320,955 (Direct) | View |
2024-03-10 Exercise | 2024-03-11 9:03 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 9,844 | $0 | 320,955 (Direct) | View |
2024-03-10 Option Award | 2024-03-11 9:03 pm | N/A 2034-03-10 | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 105,275 | $0 | 320,955 (Direct) | View |
2024-03-10 Tax Withholding | 2024-03-11 8:59 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 4,505 | $75.12 | 332,733 (Direct) | View |
2024-03-10 Exercise | 2024-03-11 8:59 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 9,732 | $0 | 332,733 (Direct) | View |
2024-03-10 Option Award | 2024-03-11 8:59 pm | N/A 2034-03-10 | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 105,275 | $0 | 332,733 (Direct) | View |
2024-02-12 Conversion | 2024-02-13 5:48 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner | 17,853,002 | $0 | 4,126,119 (Direct) | View |
Ownership | 2024-02-07 5:35 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner | 0 | $0 | 3,216,119 (Direct) | View |
2024-02-02 Option Award | 2024-02-06 6:01 pm | N/A 2034-02-02 | GILEAD SCIENCES INC. | GILD | LOVE TED W Director | 3,508 | $0 | 3,508 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 2:42 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 76,853 | $0 | 102,616 (Direct) | View |
2024-01-31 Tax Withholding | 2024-02-02 2:42 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 23,709 | $78.26 | 102,616 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 2:34 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 74,055 | $0 | 113,147 (Direct) | View |
2024-01-31 Tax Withholding | 2024-02-02 2:34 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 22,509 | $78.26 | 113,147 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 2:19 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 4,646 | $0 | 11,728 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 2:11 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 74,961 | $0 | 129,436 (Direct) | View |
2024-01-31 Tax Withholding | 2024-02-02 2:11 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 23,410 | $78.26 | 129,436 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 1:40 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 230,747 | $0 | 468,689 (Direct) | View |
2024-01-31 Tax Withholding | 2024-02-02 1:40 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 79,335 | $78.26 | 468,689 (Direct) | View |
2024-01-25 Exercise | 2024-01-26 4:31 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 514 | $0 | 38,905 (Direct) | View |
2024-01-25 Tax Withholding | 2024-01-26 4:31 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 194 | $80.23 | 38,905 (Direct) | View |
2023-12-28 Option Award | 2023-12-29 4:36 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Lofton Kevin E Director | 30 | $0 | 3,224 (Direct) | View |
Ownership | 2023-12-28 5:09 pm | N/A N/A | Arcellx Inc. | ACLX | GILEAD SCIENCES INC. 10% Owner | 0 | $0 | 6,720,803 (Direct) | View |
Ownership | 2023-12-22 4:07 pm | N/A N/A | HOOKIPA Pharma Inc. | HOOK | GILEAD SCIENCES INC. 10% Owner | 0 | $0 | 18,759,465 (Direct) | View |
2023-12-10 Tax Withholding | 2023-12-11 7:15 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 1,247 | $79.02 | 130,958 (Direct) | View |
2023-12-10 Exercise | 2023-12-11 7:15 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 2,730 | $0 | 130,958 (Direct) | View |
2023-12-10 Tax Withholding | 2023-12-11 7:10 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 1,269 | $79.02 | 112,615 (Direct) | View |
2023-12-10 Exercise | 2023-12-11 7:10 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 2,779 | $0 | 112,615 (Direct) | View |
2023-12-10 Tax Withholding | 2023-12-11 7:08 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 222 | $79.02 | 46,940 (Direct) | View |
2023-12-10 Exercise | 2023-12-11 7:08 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 518 | $0 | 46,940 (Direct) | View |
2023-12-10 Tax Withholding | 2023-12-11 7:04 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 3,341 | $79.02 | 498,583 (Direct) | View |
2023-12-10 Exercise | 2023-12-11 7:04 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 7,347 | $0 | 498,583 (Direct) | View |
2023-12-10 Tax Withholding | 2023-12-11 7:00 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 1,194 | $79.02 | 145,368 (Direct) | View |
2023-12-10 Exercise | 2023-12-11 7:00 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 2,617 | $0 | 145,368 (Direct) | View |
2023-11-10 Exercise | 2023-11-13 6:21 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 1,912 | $0 | 146,562 (Direct) | View |
2023-11-10 Tax Withholding | 2023-11-13 6:21 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 804 | $75.92 | 146,562 (Direct) | View |
2023-10-25 Exercise | 2023-10-26 5:56 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 514 | $0 | 39,099 (Direct) | View |
2023-10-25 Tax Withholding | 2023-10-26 5:56 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 243 | $78.39 | 39,099 (Direct) | View |
Ownership | 2023-10-25 7:15 pm | N/A N/A | ASSEMBLY BIOSCIENCES INC. | ASMB | GILEAD SCIENCES INC. 10% Owner | 0 | $0 | 13,073,668 (Direct) | View |
2023-09-28 Option Award | 2023-09-29 8:09 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Lofton Kevin E Director | 31 | $0 | 3,195 (Direct) | View |